Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Revenues:        
Revenues $ 2,352,630 $ 1,650,870 $ 4,436,468 $ 3,189,490
Costs and expenses:        
Costs of revenues 908,162 669,733 1,721,786 1,290,295
Research and development 265,031 229,064 523,184 448,102
Selling, general and administrative 213,479 181,909 406,740 354,540
Interest expense 37,852 38,880 76,164 78,266
Other expense (income), net 1,201 3,882 15,341 7,079
Income before income taxes 926,905 527,402 1,693,253 1,011,208
Provision (benefit) for income taxes 209,388 70,419 (92,749) 134,083
Net income 717,517 456,983 1,786,002 877,125
Less: Net income (loss) attributable to non-controlling interest 73 (268) 141 (693)
Net income attributable to KLA $ 717,444 $ 457,251 $ 1,785,861 $ 877,818
Net income per share attributable to KLA        
Basic (in dollars per share) $ 4.74 $ 2.96 $ 11.77 $ 5.67
Diluted (in dollars per share) $ 4.71 $ 2.94 $ 11.68 $ 5.62
Weighted-average number of shares:        
Basic (in shares) 151,251 154,273 151,791 154,777
Diluted (in shares) 152,331 155,560 152,886 156,057
Product        
Revenues:        
Revenues $ 1,895,769 $ 1,238,023 $ 3,525,657 $ 2,383,518
Service        
Revenues:        
Revenues $ 456,861 $ 412,847 $ 910,811 $ 805,972